Hinge Health, Inc. (HNGE)

Hinge Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023
Revenue	431.52	390.4	292.73
Revenue Growth (YoY)	-	33.37%	-
Cost of Revenue	88.64	89.81	98.55
Gross Profit	342.89	300.59	194.18
Selling, General & Admin	231.53	227.54	214.64
Research & Development	91.22	97.49	110.06
Operating Expenses	322.75	325.02	324.69
Operating Income	20.13	-24.43	-130.51
Interest & Investment Income	20.36	20.57	21.7
Other Non Operating Income (Expenses)	0.18	0.08	0.27
EBT Excluding Unusual Items	40.67	-3.78	-108.55
Merger & Restructuring Charges	-7.48	-7.48	-
Pretax Income	33.19	-11.26	-108.55
Income Tax Expense	1.52	0.68	-0.41
Net Income	31.67	-11.93	-108.14
Net Income to Common	135.84	-11.93	-108.14
Shares Outstanding (Basic)	14	14	13
Shares Outstanding (Diluted)	33	14	13
Shares Change (YoY)	-	4.16%	-
EPS (Basic)	9.67	-0.88	-8.31
EPS (Diluted)	4.07	-0.88	-8.31
Free Cash Flow	85.63	47.96	-65.89
Free Cash Flow Per Share	2.56	3.54	-5.06
Gross Margin	79.46%	77.00%	66.33%
Operating Margin	4.67%	-6.26%	-44.59%
Profit Margin	31.48%	-3.06%	-36.94%
Free Cash Flow Margin	19.84%	12.29%	-22.51%
EBITDA	22.37	-22.08	-128.39
EBITDA Margin	5.18%	-5.66%	-43.86%
D&A For EBITDA	2.24	2.35	2.13
EBIT	20.13	-24.43	-130.51
EBIT Margin	4.67%	-6.26%	-44.59%
Advertising Expenses	-	37.3	23.8

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q